Adults aged 21 to 45 years with enlarged pores, and oily skin on the forehead may be eligible for a 12-week research trial. Inclusion criteria include having a stable medical condition stable skin regimen, and if subject is female and of childbearing potential, a highly effective method of birth control must be used.
Participants will receive a treatment via injection, or be placed in the placebo group. Study treatment and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 12 weeks and involve about 6 visits to the study centre.
The following information is from ClinicalTrials.gov
Last Update Posted: February 25, 2024
Merz North America, Inc.
The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.
Condition or Disease:
Intervention/Treatment:Drug: NT 201
Ages Eligible for Study:
21 Years and 45 Years (Adult)
Sexes Eligible for Study:
Cheek pore size assessed as “large” by the investigator
Oily skin on the forehead
Treatment with Botulinum toxin (BoNT) of any serotype in the face within the last 12 months
Facial cosmetic procedure (e.g., chemical peel, photo rejuvenation, mesotherapy, photodynamic therapy, laser treatment, ultrasound treatment, tattooing of eyebrows) within the last 12 months
Treatment with any dermal filler in the face within the last 12 months
Any previous insertion of permanent material in the face, including permanent dermal fillers (e.g., silicone, polymethyl methacrylate)
Any medical condition that may put the subject at increased risk with exposure to botulinum toxin of any serotype
Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.